泌尿系统常见病原菌感染治疗的研究进展
Research Progress on the Treatment of Common Pathogenic Bacterial Infections in the Urinary System
DOI: 10.12677/acm.2025.1541171, PDF,   
作者: 包美荣：内蒙古医科大学内蒙古临床医学院，内蒙古 呼和浩特；赵建平*：内蒙古自治区人民医院检验科，内蒙古 呼和浩特
关键词: 泌尿系感染；抗生素疗法；非抗生素疗法；免疫治疗；益生菌；D-甘露糖；Urinary Tract Infection； Antibiotic Therapy； Non-Antibiotic Therapy； Immunotherapy； Probiotics； D-Mannose
摘要: 泌尿系感染作为临床常见感染性疾病，目前，临床上根据患者病情常规予以抗生素治疗，抗生素的使用以及给药途径和持续时间取决于患者个人的风险因素、感染部位及血流动力学稳定性，并根据尿培养结果(包括药敏结果)量身制定。但长期广泛使用抗生素，不仅会引起更多不良反应，还会造成尿路病原菌的抗生素耐药性增加，近年来，抗生素耐药性导致更多的抗生素在泌尿系感染治疗中的使用，并出现更多的有效和安全的非抗生素替代品。本文将为读者提供一篇有关泌尿系感染治疗方面的综述，包括抗生素和非抗生素对泌尿系感染的最新治疗情况，为临床预防以及治疗泌尿系感染提供新的诊治思路。
Abstract: As a common clinical infectious disease, urinary tract infection is routinely treated with antibiotics according to the patient’s condition at present. The use of antibiotics and the route and duration of administration depend on the patient’s personal risk factors, infection site and hemodynamic stability, and are tailored according to the results of urine culture (including drug sensitivity). However, long-term widespread use of antibiotics will not only cause more adverse reactions, but also increase the antibiotic resistance of urinary tract pathogens. In recent years, antibiotic resistance has led to the use of more antibiotics in the treatment of urinary tract infections, and there are more effective and safe non-antibiotic substitutes. This article will provide readers with a relatively comprehensive review on the treatment of urinary tract infections, including the latest treatment of urinary tract infections with antibiotics and non-antibiotics, and provide new ideas for clinical prevention and treatment of urinary tract infections.
文章引用：包美荣, 赵建平. 泌尿系统常见病原菌感染治疗的研究进展[J]. 临床医学进展, 2025, 15(4): 2201-2210. https://doi.org/10.12677/acm.2025.1541171

参考文献

[1] 尿路感染诊断与治疗中国专家共识编写组. 尿路感染诊断与治疗中国专家共识(2015版)——尿路感染抗菌药物选择策略及特殊类型尿路感染的治疗建议[J]. 中华泌尿外科杂志, 2015, 36(4): 245-248.
[2] Hakimi, S., Dutta, P. and Layton, A.T. (2023) Coupling of Renal Sodium and Calcium Transport: A Modeling Analysis of Transporter Inhibition and Sex Differences. American Journal of Physiology-Renal Physiology, 325, F536-F551. [Google Scholar] [CrossRef] [PubMed]
[3] Corse, T.D., Rahmani, L.D., Hasley, H.L., Kim, K., Harrison, R. and Fromer, D.L. (2023) New Avenue of Diagnostic Stewardship: Procedural Stewardship for Recurrent Urinary Tract Infections in Female Patients. Antimicrobial Stewardship & Healthcare Epidemiology, 3, e231-e507. [Google Scholar] [CrossRef] [PubMed]
[4] Ross, J. and Hickling, D. (2022) Medical Treatment for Urinary Tract Infections. Urologic Clinics of North America, 49, 283-297. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, Y., Lee, W. and Chuang, Y. (2023) Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection. International Journal of Molecular Sciences, 24, Article No. 7055. [Google Scholar] [CrossRef] [PubMed]
[6] Grammatico-Guillon, L., Laurent, E., Fuhrman, J., Gaborit, C., Vallée, M., Dinh, A., et al. (2023) Factors Associated with Urinary Diversion and Fatality of Hospitalised Acute Pyelonephritis Patients in France: A National Cross-Sectional Study (FUrTIHF-2). Epidemiology and Infection, 151, e161-e504. [Google Scholar] [CrossRef] [PubMed]
[7] 程桂青, 李晓, 周惠惠, 等. 尿路感染患者常见病原菌分布及耐药性分析[J]. 徐州医科大学学报, 2023, 43(7): 504-509.
[8] 袁瑾懿, 林东昉. 2022年美国感染病学会对产超广谱β内酰胺酶肠杆菌目细菌、碳青霉烯类耐药肠杆菌目细菌和难治性耐药铜绿假单胞菌感染的治疗指导[J]. 中国感染与化疗杂志, 2023, 23(2): 265-271.
[9] Garcia-Bustos, V., Cabañero-Navalón, M.D. and Salavert Lletí, M. (2022) Resistance to Beta-Lactams in Gram-Negative Bacilli: Relevance and Potential Therapeutic Alternatives. Revista Española de Quimioterapia, 35, 1-15. [Google Scholar] [CrossRef] [PubMed]
[10] Lima, L.M., Silva, B.N.M.d., Barbosa, G. and Barreiro, E.J. (2020) β-Lactam Antibiotics: An Overview from a Medicinal Chemistry Perspective. European Journal of Medicinal Chemistry, 208, Article ID: 112829. [Google Scholar] [CrossRef] [PubMed]
[11] Muteeb, G. (2023) Network Meta-Analysis of Antibiotic Resistance Patterns in Gram-Negative Bacterial Infections: A Comparative Study of Carbapenems, Fluoroquinolones, and Aminoglycosides. Frontiers in Microbiology, 14, 1304-1311. [Google Scholar] [CrossRef] [PubMed]
[12] Waldron, J.L., Rose, M., Vogrin, S., Krantz, M.S., Bolotte, R., Phillips, E.J., et al. (2023) Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule. JAMA Network Open, 6, e23167-e23176. [Google Scholar] [CrossRef] [PubMed]
[13] MacGowan, A.P. and Bowker, K.E. (2003) Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an in Vitro Pharmacokinetic Model. Antimicrobial Agents and Chemotherapy, 47, 1096-1100. [Google Scholar] [CrossRef] [PubMed]
[14] Amladi, A.U., Abirami, B., Devi, S.M., Sudarsanam, T.D., Kandasamy, S., Kekre, N., et al. (2019) Susceptibility Profile, Resistance Mechanisms & Efficacy Ratios of Fosfomycin, Nitrofurantoin & Colistin for Carbapenem-Resistant Enterobacteriaceae Causing Urinary Tract Infections. Indian Journal of Medical Research, 149, 185-191. [Google Scholar] [CrossRef] [PubMed]
[15] Chi, J., Li, Y., Zhang, N., Liu, H., Chen, Z., Li, J., et al. (2023) Fosfomycin Enhances the Inhibition Ability of Linezolid against Biofilms of Vancomycin-Resistant Enterococcus faecium in Vitro. Infection and Drug Resistance, 16, 7707-7719. [Google Scholar] [CrossRef] [PubMed]
[16] AL Rubaye, M., Janice, J., Bjørnholt, J.V., Kacelnik, O., Haldorsen, B.C., Nygaard, R.M., et al. (2023) The Population Structure of Vancomycin-Resistant and-Susceptible Enterococcus faecium in a Low-Prevalence Antimicrobial Resistance Setting Is Highly Influenced by Circulating Global Hospital-Associated Clones. Microbial Genomics, 9, Article ID: 001160. [Google Scholar] [CrossRef] [PubMed]
[17] Zeitoun, H., Salem, R.A., El-Guink, N.M., Tolba, N.S. and Mohamed, N.M. (2024) Elucidation of the Mechanisms of Fluconazole Resistance and Repurposing Treatment Options against Urinary Candida Spp. Isolated from Hospitalized Patients in Alexandria, Egypt. BMC Microbiology, 24, Article No. 383. [Google Scholar] [CrossRef] [PubMed]
[18] Mhade, S., Uppal, G.K. and Bapat, S. (2020) Computational Studies for Evaluation of Azole and Flucytosine Drugs against Candida Auris to Study Antifungal Resistance. International Journal of Infectious Diseases, 101, Article No. 389. [Google Scholar] [CrossRef] 
[19] Bao, K., Liang, Y., Zhu, L., Wu, S., Zhao, X., Ni, S., et al. (2025) Amphotericin B Delivery Systems: Current Advances and Potential Directions in Oral Candidiasis Treatment. Precision Medicine and Engineering, 2, Article ID: 100021. [Google Scholar] [CrossRef] 
[20] Barsegian, V.A.B. and Kosova, I.V.K. (2022) Role of the Lower Urinary Tract Viral Infections in the Development of Female Micturition Disorders. Urologiia, 5, 117-122. [Google Scholar] [CrossRef] 
[21] Stubbee, R.A., Orzel, J. and Tracy, C.R. (2024) Best Practices in Treatment of Fungal Urinary Tract Infections. Urologic Clinics of North America, 51, 483-492. [Google Scholar] [CrossRef] [PubMed]
[22] Díaz-García, J., Machado, M., Alcalá, L., Reigadas, E., Pérez-Ayala, A., Gómez-García de la Pedrosa, E., et al. (2023) Trends in Antifungal Resistance in Candida from a Multicenter Study Conducted in Madrid (CANDIMAD Study): Fluconazole-Resistant C. parapsilosis Spreading Has Gained Traction in 2022. Antimicrobial Agents and Chemotherapy, 67, e00986-e01009. [Google Scholar] [CrossRef] [PubMed]
[23] Henry, A.B., Alexander, J.S.S. and Jirehl, V.P. (2023) High Frequency of Lamivudine and Telbivudine Resistance Mutations in Hepatitis B Virus Isolates from Human Immunodeficiency Virus Co-Infected Patients on Highly Active Antiretroviral Therapy in Bucaramanga, Colombia. Frontiers in Microbiology, 14, Article ID: 1202342.
[24] Gebremedhin, K.B., Yisma, E., Alemayehu, H., Medhin, G., Belay, G., Bopegamage, S., et al. (2024) Urinary Tract Infection among People Living with Human Immunodeficiency Virus Attending Selected Hospitals in Addis Ababa and Adama, Central Ethiopia. Frontiers in Public Health, 12, Article ID: 1394842. [Google Scholar] [CrossRef] [PubMed]
[25] Sachdeva, A., Rai, B.P., Veeratterapillay, R., Harding, C. and Nambiar, A. (2024) Non-Steroidal Anti-Inflammatory Drugs for Treating Symptomatic Uncomplicated Urinary Tract Infections in Non-Pregnant Adult Women. Cochrane Database of Systematic Reviews, 2024, CD014762. [Google Scholar] [CrossRef] [PubMed]
[26] Werneburg, G.T., Rhoads, D.D., Milinovich, A., McSweeney, S., Knorr, J., Mourany, L., et al. (2024) External Validation of Predictive Models for Antibiotic Susceptibility of Urine Culture. BJU International, 135, 629-637. [Google Scholar] [CrossRef] [PubMed]
[27] Daniel, V.R., Ruijie, Y., Christopher, E.B., et al. (2024) Incidence and Risk Factors for Catheter-Associated Urinary Tract Infection in 623 Intensive Care Units throughout 37 Asian, African, Eastern European, Latin American, and Middle Eastern Nations: A Multinational Prospective Research of INICC. Infection Control and Hospital Epidemiology, 45, 1-9.
[28] Nawaz, S., Baber, Z.U., Dodani, S.K., Jamil, S. and Nasim, A. (2024) Microbiology and Risk Factors for Bacteremic Urinary Tract Infection: Insights from the Largest Urological Center in Pakistan. International Urology and Nephrology. [Google Scholar] [CrossRef] [PubMed]
[29] Tamma, P.D., et al. (2023) Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clinical Infectious Diseases, ciad428.
[30] Politis, P.A. and File, T.M. (2019) Highlights of Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Infectious Diseases in Clinical Practice, 27, 308-309. [Google Scholar] [CrossRef] 
[31] Schmiemann, G., Kranz, J., Mandraka, F., Schubert, S., Wagenlehner, F. and Gágyor, I. (2024) The Diagnosis, Treatment, and Prevention of Recurrent Urinary Tract Infection. Deutsches Ärzteblatt International, 121, 373-382. [Google Scholar] [CrossRef] [PubMed]
[32] Sher, E.K., Džidić-Krivić, A., Sesar, A., Farhat, E.K., Čeliković, A., Beća-Zećo, M., et al. (2024) Current State and Novel Outlook on Prevention and Treatment of Rising Antibiotic Resistance in Urinary Tract Infections. Pharmacology & Therapeutics, 261, Article ID: 108688. [Google Scholar] [CrossRef] [PubMed]
[33] Shah Utsav, S., Subramaniam, V. and Tamhankar Ashwin, S. (2021) Microbiome Studies in Urology—Where Do We Stand and Where Can We Reach? Indian Journal of Medical Microbiology, 39, 98-103. [Google Scholar] [CrossRef] [PubMed]
[34] Vagios, S., Hesham, H. and Mitchell, C. (2020) Understanding the Potential of Lactobacilli in Recurrent UTI Prevention. Microbial Pathogenesis, 148, Article ID: 104544. [Google Scholar] [CrossRef] [PubMed]
[35] Akter, M., Jannnat, R. and Nova, T.T. (2020) Lactobacillus Species as a Cause of Urinary Tract Infection. Journal of Dhaka Medical College, 27, 215-217. [Google Scholar] [CrossRef] 
[36] Raphael, E. and Huang, A.J. (2024) Antibiotic-Sparing Prevention of Urinary Tract Infections—New Evidence Regarding D-Mannose. JAMA Internal Medicine, 184, 629-630. [Google Scholar] [CrossRef] [PubMed]
[37] Johari, F. and Johari, P. (2024) Cranberry Products for Preventing Urinary Tract Infections. American Family Physician, 110, Online.
[38] Xiong, Z., Gao, Y., Yuan, C., Jian, Z. and Wei, X. (2024) Preventive Effect of Cranberries with High Dose of Proanthocyanidins on Urinary Tract Infections: A Meta-Analysis and Systematic Review. Frontiers in Nutrition, 11, Article ID: 1422121. [Google Scholar] [CrossRef] [PubMed]
[39] Williams, G., Hahn, D., Stephens, J.H., Craig, J.C. and Hodson, E.M. (2023) Cranberries for Preventing Urinary Tract Infections. Cochrane Database of Systematic Reviews, 2023, CD001321. [Google Scholar] [CrossRef] [PubMed]
[40] Borran, M., Dashti-Khavidaki, S., Alamdari, A., Naderi, N. and Gatmiri, S.M. (2020) High-Dose Intravenous Vitamin C Reduces Urinary Tract Infection Post-Kidney Transplantation. African Journal of Urology, 26, 1-4. [Google Scholar] [CrossRef] 
[41] Zakharova, I.N., Tsutsaeva, A.N., Dolbnya, S.V., Kuryaninova, V.A., Klimov, L.Y., Minasyan, А.K., et al. (2021) Urinary Tract Infections and Vitamin D: Prospects for Use in Prevention and Treatment. Medical Council, 148-155. [Google Scholar] [CrossRef] 
[42] Ali, S.B., Perdawood, D., Abdulrahman, R., Al Farraj, D.A. and Alkubaisi, N.A. (2020) Vitamin D Deficiency as a Risk Factor for Urinary Tract Infection in Women at Reproductive Age. Saudi Journal of Biological Sciences, 27, 2942-2947. [Google Scholar] [CrossRef] [PubMed]
[43] Nashivochnikova, N.N.A., Krupin, K.V.N., Zubova, Z.S.Y. and Leanovich V, L.V.E. (2023) The Role of Phytoestrogens in the Complex Therapy and Prevention of the Recurrent Lower Urinary Tract Infection in Climacteric Patients. Akusherstvo i Ginekologiia, 8, 141-152. [Google Scholar] [CrossRef] 
[44] Lenger, S.M., et al. (2022) Feasibility and Research Insights from a Randomized Controlled Trial for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen Therapy. Female Pelvic Medicine & Reconstructive Surgery, 28, e163-e170.
[45] He, M., Yin, Y., Yu, G. and Zhou, H. (2024) Phytoestrogens: Pharmacological Potential and Therapeutic Insights for Urinary Tract Infections. Phytotherapy Research, 39, 1261-1276. [Google Scholar] [CrossRef] [PubMed]
[46] Bittencourt, A.A., Paula, M.D.N.d., Ribeiro-Pereira, A.C.P., Batista, P.d.M. and Polis, T.J. (2025) An Integrative Review on Treatment Guidelines for Complicated Urinary Tract Infections: A Synthesis of Evidence-Based Recommendations. Revista do Instituto de Medicina Tropical de São Paulo, 67, e7. [Google Scholar] [CrossRef] [PubMed]
[47] David, C., Popescu, P., Rădulescu, D. and Văcăroiu, I.A. (2022) Targeted Immunomodulation Therapies as New Options to Cure Urinary Tract Infections. Internal Medicine, 19, 17-22. [Google Scholar] [CrossRef] 
[48] Liu, C., Su, W., Tan, Z., Zhang, J. and Dong, W. (2023) The Interaction between Microbiota and Immune in Intestinal Inflammatory Diseases: Global Research Status and Trends. Frontiers in Cellular and Infection Microbiology, 13, Article ID: 1128249. [Google Scholar] [CrossRef] [PubMed]

为你推荐